A Protocol for Extraction of Infective Viromes Suitable for Metagenomics Sequencing from Low Volume Fecal Samples.
T4
c2
human gut phageome
human gut virome
isolation
microbiome
phage
phi29
phiX174
purification
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
20 07 2019
20 07 2019
Historique:
received:
11
06
2019
revised:
10
07
2019
accepted:
18
07
2019
entrez:
24
7
2019
pubmed:
25
7
2019
medline:
18
8
2020
Statut:
epublish
Résumé
The human gut microbiome (GM) plays an important role in human health and diseases. However, while substantial progress has been made in understanding the role of bacterial inhabitants of the gut, much less is known regarding the viral component of the GM. Bacteriophages (phages) are viruses attacking specific host bacteria and likely play important roles in shaping the GM. Although metagenomic approaches have led to the discoveries of many new viruses, they remain largely uncultured as their hosts have not been identified, which hampers our understanding of their biological roles. Existing protocols for isolation of viromes generally require relatively high input volumes and are generally more focused on extracting nucleic acids of good quality and purity for down-stream analysis, and less on purifying viruses with infective capacity. In this study, we report the development of an efficient protocol requiring low sample input yielding purified viromes containing phages that are still infective, which also are of sufficient purity for genome sequencing. We validated the method through spiking known phages followed by plaque assays, qPCR, and metagenomic sequencing. The protocol should facilitate the process of culturing novel viruses from the gut as well as large scale studies on gut viromes.
Identifiants
pubmed: 31330855
pii: v11070667
doi: 10.3390/v11070667
pmc: PMC6669555
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : CIHR
Pays : Canada
Références
Nat Rev Microbiol. 2005 Jun;3(6):504-10
pubmed: 15886693
Int J Syst Evol Microbiol. 2006 Jul;56(Pt 7):1639-43
pubmed: 16825642
Nat Protoc. 2009;4(4):470-83
pubmed: 19300441
Nature. 2010 Jul 15;466(7304):334-8
pubmed: 20631792
Genome Res. 2011 Oct;21(10):1616-25
pubmed: 21880779
Nat Rev Microbiol. 2012 Sep;10(9):607-17
pubmed: 22864264
ISME J. 2013 Jul;7(7):1253-5
pubmed: 23407309
Nucleic Acids Res. 2013 May 1;41(10):e108
pubmed: 23558742
Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12450-5
pubmed: 23836644
Folia Microbiol (Praha). 1978;23(1):88-96
pubmed: 23986
Genome Biol. 2014 Mar 03;15(3):R46
pubmed: 24580807
World J Gastroenterol. 2014 Nov 21;20(43):16062-78
pubmed: 25473158
BMC Genomics. 2015 Jan 22;16:7
pubmed: 25608871
Dig Liver Dis. 2015 Dec;47(12):1007-12
pubmed: 26257129
Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11941-6
pubmed: 26351661
Nat Med. 2015 Oct;21(10):1228-34
pubmed: 26366711
Front Microbiol. 2015 Sep 11;6:918
pubmed: 26441861
Sci Rep. 2015 Nov 12;5:16532
pubmed: 26559140
Microbiome. 2015 Nov 17;3:64
pubmed: 26577924
FEMS Microbiol Rev. 2016 Mar;40(2):258-72
pubmed: 26657537
FEMS Microbiol Lett. 2016 May;363(10):
pubmed: 27030726
Viruses. 2016 May 04;8(5):
pubmed: 27153081
Nature. 2016 Aug 25;536(7617):425-30
pubmed: 27533034
PeerJ. 2016 Dec 8;4:e2777
pubmed: 28003936
Nat Neurosci. 2017 Feb;20(2):145-155
pubmed: 28092661
Genome Res. 2017 May;27(5):824-834
pubmed: 28298430
PLoS One. 2017 Mar 24;12(3):e0174223
pubmed: 28339484
Bioinformatics. 2017 Oct 1;33(19):3113-3114
pubmed: 28957499
Microbiome. 2018 Apr 10;6(1):68
pubmed: 29631623
Methods Mol Biol. 2018;1838:85-95
pubmed: 30128991
Cell Host Microbe. 2019 Feb 13;25(2):195-209
pubmed: 30763534
Viruses. 2019 May 13;11(5):null
pubmed: 31086117